Abstract
T1324 Administrative Claims Data Analysis of Certolizumab Pegol in Crohn's Disease PTS Demonstrates Low Rates of Dose Escalation and High Compliance and Persistency
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
